0001724521-24-000030.txt : 20240125
0001724521-24-000030.hdr.sgml : 20240125
20240125194014
ACCESSION NUMBER: 0001724521-24-000030
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240123
FILED AS OF DATE: 20240125
DATE AS OF CHANGE: 20240125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Goeltz II Robert C.
CENTRAL INDEX KEY: 0001653881
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38419
FILM NUMBER: 24563705
MAIL ADDRESS:
STREET 1: 343 OYSTER POINT BLVD
STREET 2: SUITE 100
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arcus Biosciences, Inc.
CENTRAL INDEX KEY: 0001724521
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 473898435
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3928 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
BUSINESS PHONE: (510) 694-6200
MAIL ADDRESS:
STREET 1: 3928 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
4
1
wk-form4_1706229604.xml
FORM 4
X0508
4
2024-01-23
0
0001724521
Arcus Biosciences, Inc.
RCUS
0001653881
Goeltz II Robert C.
C/O ARCUS BIOSCIENCES, INC.
3928 POINT EDEN WAY
HAYWARD
CA
94545
0
1
0
0
Chief Financial Officer
0
Common Stock
2024-01-23
4
A
0
21300
0
A
73131
D
Stock Option (right to buy)
15.44
2024-01-23
4
A
0
86600
0
A
2034-01-22
Common Stock
86600
86600
D
Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2024, subject to the Reporting Person's continued service to the Company.
The option becomes exercisable in 48 equal monthly installments after January 1, 2024, subject to the Reporting Person's continued service to the Company.
/s/ Carolyn Tang, Attorney-in-Fact
2024-01-25